Pfizer expects 8 blockbuster cancer drugs to come from each of 4 focus areas: exec

During a recent investor event dedicated to the newly expanded oncology business, Pfizer unveiled a goal to have eight blockbuster cancer drugs by 2030 but fell short of naming specific products.